bpc-157 safety human study adverse events Peptide BPC-157: What you need to
Description
This is a theoretical risk, not a demonstrated one, and it should factor into who avoids this stack (see below)
The compound has a half-life of approximately six days, which allows for convenient once-weekly dosing
It is not a blend, not pre-mixed, and not combined into a single vial
Treatment is typically lifelong for patients with pernicious anaemia or irreversible malabsorption conditions
For a visual walkthrough of this same process applied to other peptides, our guide to mixing peptides with bac water covers the universal technique
